Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study

Breast Cancer Research : BCR
Minoru MiyashitaTakanori Ishida

Abstract

The status of tumor-infiltrating lymphocytes (TILs) has been recently proposed to predict clinical outcome of patients with breast cancer. We therefore studied the prognostic significance of CD8(+) TILs and FOXP3(+) TILs in residual tumors after neoadjuvant chemotherapy (NAC) and the alterations in these parameters before and after NAC in patients with triple-negative breast cancer (TNBC). One hundred thirty-one TNBC patients who received NAC at three institutions were examined. CD8(+) TIL and FOXP3(+) TIL in residual tumors and biopsy specimens were evaluated by double-staining immunohistochemistry. The CD8(+) TIL and FOXP3(+) TIL status of the residual tumors was assessed, and the rates of their changes before and after NAC were calculated. TNBC patients with high CD8(+) TIL levels or a high CD8/FOXP3 ratio in residual tumors had significantly better recurrence-free survival (RFS) and breast cancer-specific survival (BCSS) than patients with low values of these parameters. In multivariate analyses, CD8(+) TIL exhibited strong prognostic significance for RFS, with a hazard ratio (HR) of 3.09 (95 % confidence interval (CI) 1.537-6.614, P=0.0013). The CD8/FOXP3 ratio was also significantly correlated with RFS (HR=2.07, 95 % CI 1...Continue Reading

References

Aug 1, 1994·Immunity·T L WalunasJ A Bluestone
Aug 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Udaya K LiyanageDavid C Linehan
Jan 17, 2003·The New England Journal of Medicine·Lin ZhangGeorge Coukos
Jun 11, 2003·Nature Immunology·Norihiko WatanabeKenneth M Murphy
Jul 9, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Manuelle ViguierLaurent Ferradini
Sep 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ander UrruticoecheaMitch Dowsett
Nov 23, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce G HafftyDeborah Toppmeyer
Dec 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonio C WolffUNKNOWN College of American Pathologists
Aug 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rebecca DentSteven A Narod
Sep 6, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W Fraser SymmansLajos Pusztai
Sep 22, 2007·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Enrique LermaAgustí Barnadas
Feb 5, 2008·Cancer Research·Neil H SegalJames P Allison
Feb 6, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cornelia LiedtkeLajos Pusztai
Apr 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sylvain LadoireFrançois Ghiringhelli
May 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Emad A RakhaIan O Ellis
Jun 11, 2008·Breast Cancer Research and Treatment·Rebecca DentSteven A Narod
Jun 18, 2010·Breast Cancer Research and Treatment·Sahar M A MahmoudAndrew R Green
Mar 3, 2011·Nature Reviews. Clinical Oncology·Laurence ZitvogelGuido Kroemer
Mar 26, 2011·The Journal of Pathology·Sylvain LadoireFrançois Ghiringhelli
Apr 13, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sahar M A MahmoudAndrew R Green
Mar 17, 2012·Breast Cancer Research : BCR·Shuzhen LiuTorsten O Nielsen
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Jun 5, 2012·The New England Journal of Medicine·Julie R BrahmerJon M Wigginton
Dec 22, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Fabrice AndreSherene Loi
Jun 4, 2013·The New England Journal of Medicine·Omid HamidAntoni Ribas
Jan 10, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M V DieciF Andre
May 21, 2014·Breast Cancer Research and Treatment·S MuenstS D Soysal
Jun 12, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H R AliC Caldas
Jul 30, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sylvia AdamsSunil S Badve
Sep 13, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R SalgadoUNKNOWN International TILs Working Group 2014
Nov 2, 2014·Breast Cancer Research and Treatment·Ezzeldin M IbrahimGhieth A Kazkaz
Jan 22, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edith A PerezMonica M Reinholz
Mar 1, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M V DieciF Andre

❮ Previous
Next ❯

Citations

Sep 22, 2015·Pharmacology & Therapeutics·Johan M van RooijenElisabeth G E de Vries
Feb 9, 2016·Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology·Shaheenah Dawood
Dec 8, 2016·International Journal of Cancer. Journal International Du Cancer·Sheng ChenZhi-Ming Shao
Apr 11, 2017·European Journal of Immunology·Lydia Dyck, Kingston H G Mills
Apr 6, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Andrea RavelliDaniele Generali
Sep 3, 2016·International Journal of Molecular Sciences·Joseph FabreReem Al-Dacak
Dec 9, 2017·International Journal of Cancer. Journal International Du Cancer·Aya S KhairallahAlexandra Leary
Apr 16, 2016·Clinical Medicine Insights. Oncology·Paula García-TeijidoYolanda Fernández Pérez
Oct 26, 2016·World Journal of Clinical Oncology·Carlos A CastanedaTatiana Vidaurre
Feb 22, 2018·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Marie Colombe AgahozoCarolien H M van Deurzen
Aug 8, 2018·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·T Konno-KumagaiH Sasano
May 13, 2018·BMC Cancer·Joshua P BatesTonya J Webb
Feb 20, 2019·Journal of Experimental & Clinical Cancer Research : CR·Murugan KalimuthoKum Kum Khanna
Dec 8, 2019·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Bo CaiJun Zhang
Jan 17, 2019·Oncotarget·Catherine GérardNatacha Rocks
Jul 2, 2020·Cancer Biotherapy & Radiopharmaceuticals·Li LiKunxian Yang
Aug 21, 2020·Journal for Immunotherapy of Cancer·Natasha D SheybaniRichard J Price
Feb 18, 2016·Current Opinion in Obstetrics & Gynecology·Leisha A EmensLaureen S Ojalvo
Oct 28, 2016·Breast Cancer Research and Treatment·Michael J CampbellLaura Esserman
Jul 28, 2016·Clinical & Experimental Metastasis·Thomas SchweigerKonrad Hoetzenecker
Aug 4, 2019·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Marie Colombe AgahozoCarolien H M van Deurzen
Feb 26, 2020·International Journal of Molecular Sciences·Monika BednarczykMatthias Bros
Mar 22, 2018·Technology in Cancer Research & Treatment·Mariel Garcia-ChagollanLuis Felipe Jave-Suárez

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Software Mentioned

SAS
JMP Pro

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.